Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -357,319 | N/A | -273,887 | -153,266 | -59,136 |
| Depreciation Amortization | 3,872 | N/A | 3,209 | 1,817 | 2,237 |
| Accounts receivable | -295 | N/A | 452 | 103 | -190 |
| Other Working Capital | 78,073 | N/A | -8,195 | 15,842 | 4,694 |
| Other Operating Activity | 53,227 | 0 | 144,995 | 73,254 | 3,934 |
| Operating Cash Flow | $-222,442 | $N/A | $-133,426 | $-62,250 | $-48,462 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -10,380 | -131,610 | 48,101 |
| PPE Investments | -6,849 | N/A | -9,975 | -1,837 | -2,226 |
| Sale Of Investment | N/A | N/A | 95,112 | 57,183 | N/A |
| Investing Cash Flow | $-6,849 | $N/A | $74,757 | $-76,264 | $45,875 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 182,216 | N/A | N/A |
| Common Stock Issued | 347,181 | N/A | 447,738 | 47,568 | 2,733 |
| Other Financing Activity | 0 | 0 | -2,051 | 121,236 | -369 |
| Financing Cash Flow | $347,181 | $N/A | $627,903 | $168,804 | $2,364 |
| Exchange Rate Effect | -22 | N/A | -46 | -100 | -26 |
| Beginning Cash Position | 494,173 | N/A | 43,394 | 13,204 | 13,453 |
| End Cash Position | 612,041 | N/A | 612,582 | 43,394 | 13,204 |
| Net Cash Flow | $117,868 | $N/A | $569,188 | $30,190 | $-249 |
| Free Cash Flow | |||||
| Operating Cash Flow | -222,442 | N/A | -133,426 | -62,250 | -48,462 |
| Capital Expenditure | -6,849 | N/A | -9,975 | -1,837 | -2,226 |
| Free Cash Flow | -229,291 | 0 | -143,401 | -64,087 | -50,688 |